A year ago
human papillomavirus (HPV) vaccine has been shown to be an effective way to prevent certain types of cancers, including cervical cancer. However, in many parts of the world, vaccine coverage remains low, particularly in low- and middle-income countries. In Uganda, the HPV vaccine is available, but coverage remains low. A recent study sought to identify the factors associated with HPV vaccine coverage in Gulu District, Uganda.
The study, which was conducted by researchers from Gulu University and Makerere University, surveyed 471 households in Gulu District to determine HPV vaccine coverage among girls aged 9-13. The researchers also collected data on various factors that could influence vaccine coverage, such as knowledge and attitudes towards the vaccine, socio-economic status, and access to healthcare
.
The results of the study showed that HPV vaccine coverage in Gulu District was low, with only 23.9% of girls aged 9-13 having received the vaccine. The researchers identified several factors that were associated with vaccine coverage. These included:
Knowledge and attitudes towards the vaccine: Girls whose parents had a positive attitude towards the HPV vaccine and who had received information about the vaccine from health workers were more likely to be vaccinated.
Socio-economic status: Girls from households with higher income and education levels were more likely to be vaccinated.
Access to healthcare: Girls who lived closer to a health facility and who had a regular source of healthcare were more likely to be vaccinated.
The researchers also found that there were several barriers to HPV vaccine coverage in Gulu District. These included a lack of knowledge and awareness about the vaccine, concerns about the safety and effectiveness of the vaccine, and a lack of trust in the healthcare system.
The findings of this study highlight the need for targeted efforts to improve HPV vaccine coverage in Uganda. These efforts should focus on increasing knowledge and awareness about the vaccine, addressing concerns about safety and effectiveness, and improving access to healthcare services. Additionally, efforts should be made to address the socio-economic barriers that may prevent some girls from accessing the vaccine.
In conclusion, the low HPV vaccine coverage in Gulu District, Uganda is a cause for concern, given the potential of the vaccine to prevent cervical cancer. The factors associated with vaccine coverage identified in this study can help inform efforts to improve coverage and reduce the burden of cervical cancer in Uganda. By addressing the barriers to vaccine coverage and increasing awareness and access to the vaccine, Uganda can make significant progress towards reducing the incidence of cervical cancer and improving the health of its population.
Total Comments: 0